Category: tools-profils-members

Director, represented by Sandrine FLORY TSGH SAS has been Transgene’s reference shareholder since 1994. This financial holding company is a member of Institut Mérieux Group and is in fine owned by the Mérieux family and by the Christophe and Rodolphe Mérieux Foundation. Philippe Archinard is CEO of TSGH. Sandrine Flory has been TSGH’s permanent representative… Continue reading Sandrine Flory TSGH

Independent Director Maya Said has been an independent Director of Transgene since 2017. She brings more than 15 years of international experience in the healthcare industry. Previously, she was Vice-President, Senior Global Head of Oncology Policy and Market Access at Novartis, and Vice President, Head of Strategy, Science Policy & External Innovation, Global R&D at… Continue reading Maya SAID

Honorary Chairman Alain Mérieux is Chairman of Institut Mérieux, a family holding company dedicated to medicine and public health worldwide. In 1963, Alain Mérieux founded bioMérieux, an in vitro diagnostics company. From 1968 to 1994, he was Chairman of Institut Mérieux, which specialized in human and veterinary vaccines, before divesting the vaccine business. In 1994,… Continue reading Alain MÉRIEUX

Independent Director, Chairwoman of the Audit Committee Marie Landel founded Marie Landel & associates, now Axelia Partners, a consultancy based in Cambridge (Massachusetts) specialized in advising European companies on the creation and development of US subsidiaries. She has significant experience supporting French and European biotechnology companies in the United States. With more than 30 years… Continue reading Marie LANDEL

Director Benoît Habert is Executive Vice President and Director of the Marcel Dassault Industrial Group and is a board member of several listed and private companies. He holds an MBA from INSEAD and a Master of Business Law. Benoît Habert has been a Director of the Company since 2000. Committees: member of the Compensation Committee… Continue reading Benoît HABERT

Director Jean-Pierre Bizzari, MD, is a Doctor of Medicine, graduate of the Nice medical school and a specialist in oncology. He served as Executive Vice-President, Group Head, and Clinical Oncology Development (US, Europe, and Asia/Japan) at Celgene from 2008 to 2015. Prior to joining Celgene, he served as Vice President for Clinical Development Oncology at… Continue reading Dr. Jean-Pierre BIZZARI

Independent Director Antoine Béret was Chief Executive Officer (CEO) of Genoscience Pharma SAS and Chairman of Axenis. He graduated from École Nationale des Ponts et Chaussées and Ecole Polytechnique. Antoine Béret co-founded several companies specializing in biomedicine, including Trophos where he served as CEO until 2008 and Immunotech that he directed until 1996 when Immunotech… Continue reading Antoine BÉRET

Director, Chairman of the Strategy Committee Jean-Luc Bélingard was Chairman and Chief Executive Officer of bioMérieux S.A from 2010 to 2017. He graduated from the Ecole des Hautes Etudes Commerciales (HEC) of Paris (1971) and holds a Master of Business Administration (MBA) from Cornell University, US (1974). Since then, he has held management positions at… Continue reading Jean-Luc BÉLINGARD

Director Philippe Archinard, Ph.D. has been Executive Vice-President, Technological Innovation and Scientific Partnerships at Institut Mérieux since 2021. He was Chairman and Chief Executive Officer of Transgene from 2010 to 2020; and CEO from 2004 to 2020. Previously he was CEO of Innogenetics from 2000 to 2010. From 1985 to 2000, he held various positions… Continue reading Philippe ARCHINARD

VP, Human Resources Director Christelle SCHWOERER was appointed Director of Human Resources and joined the Executive Committee in April 2024. She joined Transgene’s Human Resources department in December 2013 as a Human Resources Assistant, after initial experience in construction and industry. Her various roles at Transgene have enabled her to develop generalist skills in human… Continue reading Gaëlle STADTLER